Intellia Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.8M | 143k | 12.82 |
| 2025-12-31 | $1.1M | 122k | 8.99 |
| 2025-09-30 | $1.6M | 93k | 17.27 |
| 2025-06-30 | $480k | 51k | 9.39 |
| 2025-03-31 | $313k | 44k | 7.13 |
| 2024-12-31 | $459k | 39k | 11.68 |
| 2024-09-30 | $12M | 583k | 20.55 |
| 2024-06-30 | $28M | 1.2M | 22.38 |
| 2024-03-31 | $45M | 1.6M | 27.51 |
| 2023-12-31 | $56M | 1.8M | 30.49 |
| 2023-09-30 | $65M | 2.0M | 31.62 |
| 2023-06-30 | $84M | 2.1M | 40.78 |
| 2023-03-31 | $70M | 1.9M | 37.27 |
| 2022-12-31 | $67M | 1.9M | 34.89 |
| 2022-03-31 | $161M | 2.2M | 72.67 |
| 2021-12-31 | $248M | 2.1M | 118.24 |
| 2021-09-30 | $315M | 2.3M | 134.15 |
| 2021-06-30 | $403M | 2.5M | 161.91 |
| 2021-03-31 | $187M | 2.3M | 80.26 |
| 2020-12-31 | $115M | 2.1M | 54.40 |
| 2020-09-30 | $29M | 1.5M | 19.88 |
| 2020-06-30 | $28M | 1.4M | 21.02 |
| 2018-06-30 | $280k | 10k | 27.39 |
| 2018-03-31 | $1.2M | 59k | 21.09 |